Purchase Order 75N91021P00082

<p>The National Cancer Institute issued a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) valued at $10,196.16 on December 9, 2020, with ultimate completion on December 10, 2020. Work is performed in Bethesda, Maryland. The order is a firm fixed-price service agreement with no set-aside designation.</p>

<p>The National Cancer Institute issued a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) valued at $14,640.00 on February 4, 2020, with ultimate completion on February 4, 2021. The firm fixed-price order covers a service agreement with place of performance in Bethesda, Maryland. No small business set-aside was used.</p>

<p>The National Cancer Institute issued a delivery order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) on August 15, 2018, with a ceiling value of $49,760.30 under the Scientific Equipment and Services GSA Schedule (FSS-66).</p> <p>Place of performance is Bethesda, MD. The order was firm fixed price with an ultimate completion date of September 15, 2018. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) valued at $178,361.58 on August 23, 2015, for maintenance service of high-throughput microscopy, automated image plate loading/unloading, and liquid handling equipment. The order carries a firm fixed-price structure with no small business set-aside. Work is performed in Bethesda, Maryland, with an ultimate completion date of August 22, 2016.</p>

Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) was awarded a Blanket Purchase Agreement (BPA) call valued at $14,140 by the National Cancer Institute on November 20, 2014, for the period of December 1, 2014 through November 30, 2015. The contract, issued on a firm fixed-price basis without set-aside designation, covers Material #BLU002Z001MC and is to be performed in Shelton, Connecticut. As a child entity of parent company Revvity Inc., Revvity Health Sciences specializes in...

<p>The National Cancer Institute awarded a purchase order to Revvity Health Sciences, Inc. for a maintenance agreement valued at $10,632.96, effective January 29, 2020, with completion by January 31, 2021. Performance took place in Shelton, Connecticut. The order is firm fixed price with no small business set-aside.</p>

PerkinElmer Inc., operating as Revvity Health Sciences, Inc., received a $10,108 firm fixed-price Blanket Purchase Agreement (BPA) call award from the National Cancer Institute (NCI) on May 19, 2015, with an ultimate completion date of June 19, 2015. The contract was performed in Shelton, Connecticut, and did not utilize a set-aside designation, reflecting the contractor's status as a large business. As a child entity of Revvity Inc., PerkinElmer Health Sciences specializes in medical imaging...

<p>The National Cancer Institute issued a purchase order to Revvity Health Sciences, Inc. for $18,108.48 on December 31, 2019, to provide service coverage for the Genetics Branch PerkinElmer Ensight system during the period January 1, 2020 through December 31, 2020. No set-aside was used. Work is performed at Bethesda, Maryland. The order is firm fixed-price with no further period of performance extensions noted.</p>

Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) was awarded a Blanket Purchase Agreement (BPA) call valued at $3,656.64 by the National Cancer Institute on March 3, 2016, with an ultimate completion date of March 31, 2017. This firm fixed-price contract, issued without a small business set-aside, was performed in Bethesda, Maryland and represents a task order against a larger BPA vehicle. As a large business contractor, Revvity Health Sciences specializes in medical imaging...

The National Cancer Institute awarded a BPA call contract valued at $7,907 to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) on November 5, 2013, with an ultimate completion date of November 6, 2014. The contract calls for the procurement of Perkin Elmer radionuclides/radioisotopes, specifically Adenosine 5'-Triphosphate [Gamma-32-P], to be performed at the contractor's facility in Shelton, Connecticut. This award utilizes a firm fixed-price pricing structure under an...